arrow_back Trending Legislation
Share share

Tianeptine Control: New Rules for Psychoactive Substances.

This act places tianeptine and its related compounds under controlled substance regulations. This means access to it will be restricted, similar to other medications requiring strict oversight. The goal is to protect public health from substances with addictive potential.
Key points
Tianeptine and its analogues will be added to the list of controlled substances, limiting their availability.
The change will take effect 90 days after the act is passed, allowing time for adjustment to the new rules.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
STAND Against Emerging Opioids Act
Print number: HR 3520
Sponsor: Rep. Panetta, Jimmy [D-CA-19]
Process start date: 2025-05-20
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Tianeptine Control: New Rules for Psychoactive Substances.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 3520.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-05-20.

What are the main provisions?

Key points include:

  • Tianeptine and its analogues will be added to the list of controlled substances, limiting their availability.
  • The change will take effect 90 days after the act is passed, allowing time for adjustment to the new rules.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Panetta, Jimmy [D-CA-19].

What is the latest detailed status?

The latest detailed status is: Introduced in House

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

Analysis and Potential Impact of HR 3520

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health Courts and Law Security